Yanpeng Liu

Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit

Bo Peng, Junjian Liu, Zhihai Wu, 2019, mAbs.

Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity

M. Zhang, Zhihai Wu, Bingliang Chen, 2021, Nature Communications.

Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA Transfection

Zhuxian Zhou, Jianbin Tang, Zhen Zhang, 2023, Advances in Materials.